In a recent post, we considered commercial entities supporting the development of induced pluripotent stem cell (iPSC) therapies. It is also important to consider the government and academic entities driving forward therapeutic progress with the cell type.
The primary non-commercial institutions working toward this goal are:
- RIKEN Center in Kobe, Japan
- Kyoto University in Kyoto, Japan
- California Institute for Regenerative Medicine (CIRM) in California, USA
Each of these important institutions and their contributions to the development of new iPSC therapies is explored in detail below.